2328 related articles for article (PubMed ID: 28779299)
21. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies.
Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD
Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune blistering dermatoses as systemic diseases.
Vassileva S; Drenovska K; Manuelyan K
Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
[TBL] [Abstract][Full Text] [Related]
23. [Bullous autoimmune dermatoses of the mucous membranes].
Didona D; Hinterseher J; Eming R
Dermatologie (Heidelb); 2022 Sep; 73(9):692-700. PubMed ID: 36006424
[TBL] [Abstract][Full Text] [Related]
24. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
Wozniak K; Kazama T; Kowalewski C
Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
[TBL] [Abstract][Full Text] [Related]
25. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
26. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
[TBL] [Abstract][Full Text] [Related]
27. [Autoantigens of subepidermal bullous autoimmune dermatoses].
Georgi M; Jainta S; Bröcker EB; Zillikens D
Hautarzt; 2001 Dec; 52(12):1079-89. PubMed ID: 11910857
[TBL] [Abstract][Full Text] [Related]
28. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory.
Schmidt E; Zillikens D
Adv Dermatol; 2000; 16():113-57; discussion 158. PubMed ID: 11094626
[TBL] [Abstract][Full Text] [Related]
30. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.
Wieme N; Lambert J; Moerman M; Geerts ML; Temmerman L; Naeyaert JM
Dermatology; 1999; 198(3):310-3. PubMed ID: 10393462
[TBL] [Abstract][Full Text] [Related]
31. Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.
Dilling A; Rose C; Hashimoto T; Zillikens D; Shimanovich I
J Dermatol; 2007 Jan; 34(1):1-8. PubMed ID: 17204094
[TBL] [Abstract][Full Text] [Related]
32. Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse.
Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN
Front Immunol; 2018; 9():570. PubMed ID: 29619029
[TBL] [Abstract][Full Text] [Related]
33. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
Peng TK; Nisengard RJ; Levine MJ; Beutner EH
Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
[TBL] [Abstract][Full Text] [Related]
34. [Epidermolysis bullosa acquisita].
Hofmann SC; Weidinger A
Hautarzt; 2019 Apr; 70(4):265-270. PubMed ID: 30887080
[TBL] [Abstract][Full Text] [Related]
35. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
Mooney E; Falk RJ; Gammon WR
Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
Gao SQ; Bystryn JC
J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
[TBL] [Abstract][Full Text] [Related]
37. Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen.
Liu Y; Shimizu H; Hashimoto T
J Dermatol Sci; 2003 Aug; 32(2):125-9. PubMed ID: 12850304
[TBL] [Abstract][Full Text] [Related]
38. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
39. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
Fine JD
J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
[TBL] [Abstract][Full Text] [Related]
40. The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.
Kamaguchi M; Iwata H
Front Immunol; 2019; 10():34. PubMed ID: 30740099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
